Ventricular Septal Rupture Following Nonsurgical Septal Reduction for Hypertrophic Cardiomyopathy: Treatment with Percutaneous Closure

Catheterization and Cardiovascular Interventions

Volumn 61, Issue 3, 2004, Pages 411-414

  Aroney, Constantine N ^a   Goh, Tiow H ^b   Hourigan, Lisa A ^a   Dyer, William ^a  

^a Holy Spirit Northside Private Hospital Australia   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Alcohol; Amplatzer; Defect; Hemolysis

Indexed keywords

CONTRAST MEDIUM; FRESH FROZEN PLASMA; LACTATE DEHYDROGENASE; SHU 508; VITAMIN K GROUP; WARFARIN;

AGED; ANEMIA; ARTICLE; CASE REPORT; CONTRAST ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM DEFECT; HEMOLYSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMPLANTATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; PROSTHESES AND IMPLANTS; VENTRICULAR SEPTAL RUPTURE;

EID: 1542287485     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10767     Document Type: Article

References (11)

1. Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95:2075-2081.
2. Faber L, Ziemssen P, Seggewiss H. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. J Am Soc Echocardiogr 2000;13:1074-1079.
3. Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001;38:1701-1706.
4. Robbins RC, Stinson EB. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996;111:586-594.
5. Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ. Ventricular septal rupture after acute myocardial infarction. N Engl J Med 2002;347:1426-1432.
6. Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction: GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) trial investigators. Circulation 2000;101:27-32.
7. Landzberg MJ, Lock JE. Transcatheter management of ventricular septal rupture after myocardial infarction. Semin Thorac Cardiovasc Surg 1998;10:128-132.
8. Lee EM, Roberts DH, Walsh KP. Transcatheter closure of a residual postmyocardial infarction ventricular septal defect with the Amplatzer septal occluder. Heart 1998;80:522-524.
9. Pienvichit P, Piemonte TC. Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder implant. Catheter Cardiovasc Interv 2001;54:490-494.
10. Chessa M, Carminati M, Cao QL, et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invas Cardiol 2002;14:322-327.
11. Joseph G, Mandalay A, Zacharias TU, George B. Severe intravascular hemolysis after transcatheter closure of a large patent ductus arteriosus using the Amplatzer duct occluder: successful resolution by intradevice coil deployment. Catheter Cardiovasc Interv 2002;55:245-249.